Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 5, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Factor D: Can blocking immune system pathway stop COVID-19?

COVID UPDATE: Decrease in daily active cases in India

Science and technology help in simplifying tumour testing

Factor D: Can blocking immune system pathway stop COVID-19?
  • BiotechToday
  • World

Factor D: Can blocking immune system pathway stop COVID-19?

bioxone October 13, 2020October 13, 2020

Husna, Amity University Kolkata

As the world is waiting anxiously for a powerful and effective vaccine against covid-19, researchers are also trying to identify how coronavirus attacks the body to stop its devastating impact. One such possible way has been discovered in a recent study by researchers of John Hopkins University. This can be done by blocking a particular protein which enables the virus to turn the immune system against healthy cells of our body.

The protein is known as Factor D which on inhibition will also reduce the deadly inflammatory responses that numerous patients get on being infected. The SARS-CoV-2 virus attaches to a healthy targeted cell of the body to cause infection using the spike proteins present on its surface. The spikes do this by seizing heparan sulphate which is a complex sugar molecule found on cell-surface of lungs, blood vessels and smooth muscles as a result of which Factor H is prevented from using sugar molecule to bind with cells. Factor H regulates the chemical signals that trigger inflammation thus preventing the immune system from harming healthy cells. Without this protection, the lungs, heart, kidneys and other organs will be destroyed by the defence mechanism of our body. The SARS-CoV-2 virus activates a cascading series of biological reactions known as an alternative pathway of complement (APC) when it ties with heparan sulphate which results in inflammation and cell destruction if misread by the immune system.

 So, the research team used normal human blood serum and three sub-units of  SARS-CoV-2 spike protein to find exactly how the virus activates APC, hijacks the immune system and destroys normal cells. They discovered that S1 and S2 sub-units bind virus to heparan sulphate leading to activation of APC cascade and blockage of  Factor H due to which Factor H confers a misdirected immune response. Further, they found that upon blocking another complement protein Factor D, which works immediately upstream within the pathway from Factor H, they were able to stop the destructive chain of events triggered by SARS-CoV-2.

Also read: CAN PHYSICAL EXERCISES IMPROVE HEALTH OF BREAST CANCER SURVIVORS?

Source: https://health.economictimes.indiatimes.com/amp/news/industry/blocking-immune-system-pathway-may-stop-covid-19-johns-hopkins-study/78596131

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged (APC) Alternative pathway of complement cascade series CORONAVIRUS COVID-19 Factor D Factor H heparin sulphate human blood serum immune system inflammation SARS-CoV-2 spike protein VACCINE

3 thoughts on “Factor D: Can blocking immune system pathway stop COVID-19?”

  1. Diwita Roy says:
    October 13, 2020 at 4:41 pm

    Good content 👍👍

    Reply
    1. Husna says:
      October 13, 2020 at 4:42 pm

      Thank you❤️

      Reply
  2. Farah Noor says:
    October 16, 2020 at 9:19 pm

    The description is so clear & precise. MashaAllah. Thankyou Husna! We all are desperately waiting & praying for an effective vaccine to be produced.

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Science and technology help in simplifying tumour testing

bioxone October 14, 2020

Camelia Bhattacharyya, Amity University Kolkata We live in a world that needs more fast methods to be used from day-to-day problems to higher or complicated forms of problems; the healthcare system is not excluded from these. Patients are needing immediate treatment after quick testing which mostly depends on the equipment and the techniques used. This […]

Tumour

Related Post

  • BiotechToday
  • World

neoDL: a model that recognizes longest survival glioblastomas

bioxone August 1, 2021July 31, 2021

Parnad Basu, Amity University Kolkata What is glioblastoma? When the cells of our body start to grow at a rapid speed and uncontrollably, a tumor is formed. A tumor can be both dangerous (malignant) and not dangerous (benign). In the case of malignant tumors, it tends to spread from one body part to the other […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Anaerobic gut fungi make way for novel antibiotic production

BioTech Today June 27, 2021June 26, 2021

Sayak Banerjee, Amity University Kolkata Secondary Metabolites as a Natural Defense System in Microbes: All living beings inherit a natural defence system for ascertaining their survival. Microorganisms are mostly dependent upon the synthesized natural products that serve as a defence system against threats posed by the environment. This enables them to fight against other microorganisms. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Biodiversity and why it needs better data archiving

bioxone September 8, 2021September 8, 2021

Shenade Annie Kerketta, Amity University Kolkata Biodiversity is known as the collection of life on Earth at all levels. It covers everything, from genes to ecosystems. In short, biodiversity not only covers rare species but all life forms. Biodiversity is important to restore the balance on Earth. Biodiversity is also important as it provides us […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy